Quality of life in relation to mood, coping strategies, and dyskinesia in parkinson's disease

Journal of Geriatric Psychiatry and Neurology

Volumn 22, Issue 2, 2009, Pages 95-102

  Montel, Sbastien ^a,c   Bonnet, Anne Marie ^b   Bungener, Catherine ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b Fdration des Maladies du Systame Nerveux   (France)

^c NONE   (France)

Author keywords

Coping strategies; Dyskinesia; Mood disorders; Parkinson's disease; Quality of life

Indexed keywords

DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA;

ADULT; AGED; ANXIETY; ARTICLE; CLINICAL ASSESSMENT; COGNITION; COPING BEHAVIOR; DEPRESSION; DYSKINESIA; EMOTION; FEMALE; HAMILTON ANXIETY SCALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; MONTGOMERY ASBERG DEPRESSION RATING SCALE; MOOD; PARKINSON DISEASE; PATIENT SELECTION; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RATING SCALE; SELF REPORT; SEMI STRUCTURED INTERVIEW; UNIFIED PARKINSON DISEASE RATING SCALE; WAYS OF COPING QUESTIONNAIRE;

ADAPTATION, PSYCHOLOGICAL; ANXIETY DISORDERS; COMORBIDITY; DEPRESSIVE DISORDER; DYSKINESIAS; FEMALE; HUMANS; MALE; MIDDLE AGED; MOOD DISORDERS; PARKINSON DISEASE; PSYCHIATRIC STATUS RATING SCALES; PSYCHOMETRICS; QUALITY OF LIFE; QUESTIONNAIRES;

EID: 65549084364     PISSN: 08919887     EISSN: 15525708     Source Type: Journal    
DOI: 10.1177/0891988708328219     Document Type: Article

References (43)

1. Dodel RC, Berger K., Oertel WH Health-related quality of life and healthcare utilisation in patients with Parkinson's disease: impact of motor fluctuations and dyskinesias. Pharmacoeconomics. 2001 ; 19: 1013-1038. (Pubitemid 33701931)
2. Pchevis M., Clarke CE, Vieregge P., et al, and Trial Study Group. Effects of dyskinesias in Parkinson's disease on quality of life and health-related costs: a prospective European study. Eur J Neurol. 2005 ; 12: 956-963. (Pubitemid 41820050)
3. Gomez-Esteban JC, Zarranz JJ, Lezcano E., et al. Influence of motor symptoms upon the quality of life of patients with Parkinson's disease. Eur Neurol. 2007 ; 57: 161-165. (Pubitemid 46385602)
4. Woitalla D., Mueller T., Russ H., Hock K., Haeger DA The management approaches to dyskinesia vary from country to country. Neuroepidemiology. 2007 ; 29: 163-169.
5. McDonald WM, Richard IH, Delong MR Prevalence, etiology, and treatment of depression in Parkinson's disease. Biol Psychiatry. 2003 ; 54: 363-375. (Pubitemid 37267863)
6. Samii A., Nutt JG, Ransom BR Parkinson's disease. Lancet. 2004 ; 363: 1783-1793. (Pubitemid 38698383)
7. Lieberman A. Depression in Parkinson's disease: a review. Acta Neurol Scand. 2006 ; 113: 1-8. (Pubitemid 44526654)
8. Hantz P., Caradoc-Davies G., Caradoc-Davies T., Weatherall M., Dixon G. Depression in Parkinson's disease. Am J Psychiatry. 1994 ; 151: 1010-1014. (Pubitemid 24208636)
9. Ranoux D. Depression and Parkinson'disease. Encephale. 2000 ; 26: 22-26.
10. Veazey C., Aki SO, Cook KF, Lai EC, Kunik ME Prevalence and treatment of depression in Parkinson's disease. J Neuropsychiatry Clin Neurosci. 2005 ; 17: 310-323. (Pubitemid 46179293)
11. Richard IH, Frank S., McDermott MP, et al. The ups and downs of Parkinson's disease: a prospective study mood and anxiety fluctuations. Cogn Behav Neurol. 2004 ; 17: 201-207. (Pubitemid 40066237)
12. Menza MA, Robertson-Hoffman DE, Bonapace AS Parkinson's disease and anxiety: comorbidity with depression. Biol Psychiatry. 1993 ; 34: 465-470. (Pubitemid 23337729)
13. Lovatt B. An overview of quality of life assessments and outcome measures. Br J Med Econ. 1992 ; 4: 1-7.
14. Slawek J., Derejko M., Lass P. Factors affecting the quality of life of patients with idiopathic Parkinson's disease-a cross-sectional study in an outpatient clinic attendees. Parkinsonism Relat Disord. 2005 ; 11: 465-468. (Pubitemid 41526999)
15. Lazarus R., Folkman S. 1984. Stress, appraisal and coping. New York: Springer.
16. Endler NS, Parker JDA, Summerfelt LJ Coping with health problems: developing a reliable and valid multidimensional measure. Psychol Assess. 1998 ; 10: 195-205. (Pubitemid 28439924)
17. Frazier LD Coping with disease-related stressors in Parkinson's disease. Gerontologist. 2000 ; 40: 53-63. (Pubitemid 30170190)
18. Frazier LD Stability and change in patterns of coping with Parkinson's disease. Int J Aging Hum Dev. 2002 ; 55: 207-231. (Pubitemid 36255281)
19. Schreurs KMG, De Ridder DTD, Bensing JM A one year study of coping, social support and quality of life in Parkinson's disease. Psychol Health. 2003 ; 15: 109-121.
20. Backer JH Stressors, social support, coping, and health dysfunction in individuals with Parkinson's disease. J gerontol Nurs. 2000 ; 26: 6-16.
21. Montel S., Bungener C. Coping and quality of life in one hundred and thirty-five subjects with multiple sclerosis. Mult Scler. 2007 ; 13: 393-401. (Pubitemid 46706001)
22. Pucheu S., Consoli SM, D'Auzac C., Frana§ais P., Issad B. Do health causal attributions and coping strategies act as moderators of quality of life in peritoneal dialysis patients? J Psychosom Res. 2004 ; 56: 317-322. (Pubitemid 38445082)
23. Daniel SE, Lees AJ Parkinson's Disease Society Brain Bank, London: overview and research. J Neural Transm Suppl. 1993 ; 39: 165-172. (Pubitemid 23216938)
24. Folstein MF, Folstein SE, Mc Hugh PR Mini mental scale: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975 ; 12: 189-198.
25. Hoehn M., Yahr M. Parkinsonism: onset, progression and mortality. Neurology. 1967 ; 17: 427-442. (Pubitemid 33596369)
26. Fahn S., Elton R. Members of the UPDRS Development Committee. In: Fahn S, Marsden CD, Calne DB, Goldstein M, eds. Recent Developments in Parkinson's Disease. Vol 2. Florham Park, NJ: Macmillan Health Care Information ; 1987: 153-163, 293-304.
27. Lecrubier Y., Weiller E., Hergueta T., et al. M.I.N.I. 5.0.0., French Version, DSM-IV. Sheehan DV & Lecrubier Y. 1999.
28. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4 th ed. Revised (DSM IV-TR Washington, DC: American Psychiatric Association ; 2000.
29. Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Brit J Psychiatry. 1979 ; 34: 382-389. (Pubitemid 9136500)
30. Jouvent R., Vindreau C., Montreuil M., Bungener C., Widlocher D. La clinique polydimensionnelle de l'humeur dpressive. Nouvelle version de l'EHD. Psychiatr Psychobiol. 1988 ; 3: 245-253. (Pubitemid 18252795)
31. Bungener C., Jouvent R., Derouesn C. Affective disturbances in Alzheimer's disease. J Am Geriatric Soc. 1996 ; 44: 1066-1071. (Pubitemid 26304549)
32. Bungener C., Jouvent R., Delaporte C. Psychopathological and emotional deficits in myotonic dystrophy. J Neurol Neurosurg Psychiatry. 1998 ; 65: 353-356. (Pubitemid 28408250)
33. Bungener C., Piquard A., Pradat PF Psychopathology in amyotrophic lateral sclerosis. A preliminary study with 27 ALS patients. Amyotroph Lateral Scler Other Motor Neuron Disord Other Motor Neuron Disord. 2005 ; 6: 221-225. (Pubitemid 43123552)
34. Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol. 1959 ; 32: 50-55.
35. Pichot P., Pull CB, von Frenckell R., Pull MC Une analyse factorielle de l'chelle d'apprciation de l'anxit de Hamilton. Psychiat Fennica (Int Edn) 1981: 181-189.
36. Vitaliano PP, Russo J., Carr JE, Maiuro RD, Becker J. The ways of coping check-list: revision and psychometric properties. Multivariate Behav Res. 1985 ; 20: 3-26.
37. Paulhan I., Nuissier J., Quintard B., Cousson F., Bourgeois M. La mesure du coping. Traduction et validation de la version Franaise de l'chelle Vitaliano. Ann Med Psychol. 1994 ; 152: 292-299. (Pubitemid 24227204)
38. Jenkinson C., Peto V., Fitzpatrick R., et al. Self reported functioning and well-being in patients with Parkinson's disease: comparison of the short-form health survey (SF-36) and the Parkinson's disease questionnaire (PDQ-39. Age Ageing. 1995 ; 24: 505-509.
39. Peto V., Jenkinson C., Fitzpatrick R., Greenhall R. The development and validation of a short measure of functioning and wellbeing for individuals with Parkinson's disease. Qual Life Res. 1995 ; 4: 241-248.
40. Auquier P., Sapin C., Ziegler M., et al. Validation of the French language version of the Parkinson's disease questionnaire, PDQ-39. Rev Neurol. 2002 ; 158: 41-50. (Pubitemid 34145520)
41. Jenkinson C., Fitzpatrick R., Peto V., Greenhall R., Hyman N. The Parkinson's disease questionnaire (PDQ-39): development and validation of a Parkinson's disease summary index score. Age Ageing. 1997 ; 26: 353-357. (Pubitemid 27448379)
42. Muller T., Russ H. Levodopa, motor fluctuations and dyskinesia in Parkinson's disease. Expert Opin Pharmacother. 2006 ; 7: 1715-1730.
43. Kuopio AM, Marttilla RJ, Helenius H. et al. The quality of life in Parkinson's disease. Mov Disord. 2000 ; 15: 216-223. (Pubitemid 30166726)